MBAI (MBAI) Stock Price & Analysis
MBAI (MBAI) fell 5.41% to USD 1.4 as of June 10, 2026 at 03:07 UTC, according to Nexqual real-time market data.
MBAI last closed at USD 1.48; the session ranged USD 1.34–1.47 on volume of 86,202 shares. Market capitalization is $10.82M, with a 52-week range of USD 0.59–3.92 (NCM). Source: Nexqual, June 10, 2026 at 03:07 UTC.
Key Statistics (as of June 10, 2026 at 03:07 UTC)
| Price | USD 1.4 |
|---|---|
| Change | ▼ 5.41% (down) |
| Previous Close | USD 1.48 |
| Open | USD 1.47 |
| Day Range | USD 1.34 – 1.47 |
| 52-Week Range | USD 0.59 – 3.92 |
| Volume | 86,202 shares |
| Market Cap | $10.82M |
| Exchange | NCM |
Technical Analysis (MBAI)
Nexqual's technical model rates MBAI "SELL" based on 1 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 03:07 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 38.97 (neutral) |
| vs SMA50 | Below (USD 1.64) |
| MACD | -0.05 (negative) |
Analyst Ratings (MBAI)
Wall Street analysts rate MBAI "None", per Nexqual as of June 10, 2026 at 03:07 UTC.
| Consensus Rating | None |
|---|
Earnings (MBAI)
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2023-09-30 | USD -0.43 vs est -0.17 ▼ miss |
| 2023-06-30 | USD -0.94 vs est -0.53 ▼ miss |
| 2023-03-31 | USD -0.76 vs est -0.74 ▼ miss |
| 2022-12-31 | USD -0.64 vs est -0.98 ▲ beat |
Source: Nexqual, June 10, 2026 at 03:07 UTC.
Financials & Fundamentals (MBAI)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | +416.71% |
| Debt / Equity | 0.47 |
| Current Ratio | 0.05 |
| Total Cash | $219,000 |
| Total Debt | $16,000 |
| Free Cash Flow | $846,875 |
Source: Nexqual, June 10, 2026 at 03:07 UTC.
Financial Health Score (MBAI)
Nexqual rates MBAI's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 03:07 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Solid — $219K cash, no debt |
| Cash Flow | Weak — Operating cash flow -$46K |
| Efficiency | Strong — ROE 417%, ROA -37.7% |
Ownership (MBAI)
| Insider Ownership | +20.82% |
|---|---|
| Institutional Ownership | +0.46% |
| Shares Outstanding | 7.73M |
| Float | 5.61M |
| Short % of Float | +1.13% |
Source: Nexqual, June 10, 2026 at 03:07 UTC.
Leadership (MBAI)
MBAI is led by David Lontini (age 44), Interim CEO & Chairman of the Board, per Nexqual as of June 10, 2026 at 03:07 UTC.
| Interim CEO & Chairman of the Board | David Lontini (age 44) |
|---|---|
| Chief Financial Officer | Alan Lewis (age 50) |
Major Backers & Investors (MBAI)
Notable institutional backers of MBAI include UBS Group AG, DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Micro Cap Portfolio, according to Nexqual as of June 10, 2026 at 03:07 UTC.
Active Investors
| Investor | Stake |
|---|---|
| UBS Group AG | 0.39% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Micro Cap Portfolio | 0.13% |
Source: Nexqual, June 10, 2026 at 03:07 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| JAGX | Jaguar Health, Inc. | USD 2.82 | ▲ 0.71% |
| FRSX | Foresight Autonomous Holdings L | USD 1.67 | ▼ 11.17% |
| TTOO | T2 Biosystems, Inc. | USD 0 | ▲ 0% |
| INUV | Inuvo, Inc. | USD 1.41 | ▲ 0% |
| SENS | Senseonics Holdings, Inc. | USD 7.43 | ▲ 11.39% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:07 UTC. This page is informational and not investment advice.